Nivolumab Demonstrates Efficacy in Preliminary Data for Gastric Cancer
July 16th 2020Yu Sunakawa, MD, PhD, discusses the data observed in the DELIVER trial, which was presented as an updated analysis of nivolumab in patients with advanced gastric cancer at the European Society of Oncology World Congress on Gastrointestinal Cancer 2020.